Skip to main content
. Author manuscript; available in PMC: 2017 Oct 18.
Published in final edited form as: Breast Cancer Res Treat. 2011 Sep 4;130(3):725–734. doi: 10.1007/s10549-011-1748-z

Table 3. Characteristics of tumor type by patient cohort and by age.

Age: <40 40–48 49–60 >60




Cohort 1 Cohort2 Cohort 1 Cohort2 Cohort1 Cohort 2 Cohort 1
Total (n) 68 56 141 166 165 205 65
Median age at diagnosis (years) 35.4 36 44 45.3 54 52.2 65.4
T stage n (%) n (%) n (%) n (%) n (%) n (%) n (%)
 T1 30 45 34 61 75 53 114 69 89 54 153 75 38 59
 T2 38 55 21 38 66 47 52 31 75 45 52 25 26 41
 T3 0 0 1 2 0 0 0 0 1 1 0 0 0 0
Comparison P = 0.015 P = 0.006 P = 0.001
Grade
 I 5 7 8 14 24 17 34 20 29 18 62 30 21 32
 II 21 32 20 36 48 34 63 38 71 43 90 44 27 42
 III 41 59 28 50 68 49 69 42 61 37 53 26 17 26
Comparison P = 0.321 P = 0.775 P = 0.009
Hormone receptor
 Positive 38 57 36 64 100 71 132 80 123 75 174 85 52 80
 Negative 30 43 20 36 41 29 34 20 42 25 31 15 13 20
Comparison P = 0.282 P = 0.109 P = 0.012
70-gene
 Good prognosis 17 25 17 30 55 39 83 50 67 41 119 58 41 63
 Poor prognosis 51 75 39 70 86 61 83 50 98 59 86 42 24 37
Comparison P = 0.506 P = 0.054 P = 0.012

Clinicopathologic characteristics of study patients by age group are shown for each cohort